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Epidemiological studies have shown that genetic factors contribute to the pathogenesis of the idiopathic inﬂam-
matory bowel diseases (IBD), Crohn disease (CD) and ulcerative colitis (UC). Recent genome scans and replication
studies have identiﬁed replicated linkage between CD and a locus on chromosome 16 (the IBD1 locus), replicated
linkage between IBD (especially UC) and a locus on chromosome 12q (the IBD2 locus), and replicated linkage
between IBD (especially CD) and a locus on chromosome 6p (the IBD3 locus). Since the estimated locus-speciﬁc
ls values for the regions of replicated linkage do not account for the overall ls in CD, and since the published
genome scans in IBD show at least nominal evidence for linkage to regions on all but two chromosomes, we
performed an independent genome scan using 751 microsatellite loci in 127 CD-affected relative pairs from 62
families. Single-point nonparametric linkage analysis using the GENEHUNTER-PLUS program shows evidence for
linkage to the adjacent D14S261 and D14S283 loci on chromosome 14q11-12 (LOD = 3.00 and 1.70, respectively),
and the maximal multipoint LOD score is observed at D14S261 (LOD = 3.60). In the multipoint analysis, nominal
evidence for linkage ( ) is observed near D2S117 (LOD = 1.25), near D3S3045 (LOD = 1.31), betweenP ! .05
D7S40 and D7S648 (LOD = 0.91), and near D18S61 (LOD = 1.15). Our ﬁnding of signiﬁcant linkage to D14S261
and the ﬁnding of suggestive linkage to the same locus in an independent study (multipoint LOD = 2.8) satisﬁes
criteria for conﬁrmed linkage, so we propose that the region of interest on chromosome 14q11-12 should be
designated the IBD4 locus.
Introduction
Crohn disease (CD) (MIM 266600) and ulcerative colitis
(UC) (MIM 191390) are the major forms of idiopathic
inﬂammatory bowel disease (IBD) (MIM 266600 and
MIM 601458) that can usually be distinguished from
each other on the basis of clinical parameters, but which
also share clinical features and unknown etiology (Lash-
ner 1995; Singleton 1995). The prevalence of IBD in
Europe and North America is ∼100-200 per 100,000
(Calkins and Mendelhoff 1995).
Greater rates of IBD in Ashkenazi Jews, familial ag-
gregation of IBD, and a greater concordance for IBD in
monozygotic than dizygotic twins indicate that there is
a genetic contribution to the pathogenesis of IBD, with
a stronger genetic inﬂuence in CD than in UC (Yang
and Rotter 1994; Duerr 1996). The relative risk to sib-
lings of affected individuals (ls) is 30–40 for CD and
10–20 for UC, and CD and UC also occur together in
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the same families with a greater frequency than would
be expected by chance (Yang and Rotter 1994; Duerr
1996).
Although genetic factors clearly contribute to IBD
susceptibility, the inheritance of IBD is not attributable
to a single gene locus; CD and UC have complex ge-
netics that involve incomplete penetrance and probably
genetic heterogeneity and more than one susceptibility
locus (Yang and Rotter 1994; Duerr 1996). Since both
forms of IBD can coexist in single families with a fre-
quency greater than expected by chance, CD and UC
are likely to share some susceptibility genes, although
there may be additional CD-speciﬁc and UC-speciﬁc
genes (Yang and Rotter 1994; Duerr 1996). Recent ge-
nome scans and replication studies have identiﬁed rep-
licated linkage between CD and a locus on chromosome
16 (the IBD1 locus [MIM 266600]) (Hugot et al. 1996;
Ohmen et al. 1996; Parkes et al. 1996; Brant et al. 1998;
Cavanaugh et al. 1998; Cho et al. 1998; Curran et al.
1998; Annese et al. 1999; Hampe et al. 1999a), repli-
cated linkage between IBD (especially UC) and a locus
on chromosome 12q (the IBD2 locus [MIM 601458])
(Satsangi et al. 1996; Duerr et al. 1998; Curran et al.
1998; Akolkar et al. 1998; Hampe et al. 1999a; Ma et
al. 1999), replicated linkage between IBD (especially
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CD) and a locus on chromosome 6p (the IBD3 locus
[MIM 604519]) (Hampe et al. 1999a, 1999b; Silverberg
et al. 1999; Yang et al. 1999), and at least nominal
evidence for linkage to regions on all but two chro-
mosomes (Hugot et al. 1996; Satsangi et al. 1996; Cho
et al. 1998; Hampe et al. 1999a; Ma et al. 1999). Since
the estimated locus-speciﬁc ls values for the regions of
replicated linkage do not account for the overall ls in




The study protocol was approved by the University
of Pittsburgh Health Sciences Institutional Review
Board. Sixty-two families containing 127 CD-affected
relative pairs and 287 total study subjects were included
in the genome scan. The CD-affected relative pairs in-
cluded 94 sibling pairs, 4 half-sibling pairs, 19 avuncular
pairs, and 10 other affected relative pairs as distant as
ﬁrst cousins once removed. Offspring of unavailable
connecting relatives were recruited whenever possible to
increase the probability of determining identity-by-de-
scent allele/haplotype sharing in the affected relative
pairs. Both parents, or one parent and at least two sib-
lings, were included in the study for 76% of the non-
founder affecteds. All study subjects were interviewed
to complete a demographic and clinical database, and
consents for release of medical records to verify diag-
noses were obtained from affected study subjects. In all
but two families, there were no known cases of UC. In
two families, we became aware of a relative with UC
after we included the families in the genome scan (a trio
of CD-affected siblings was found to have a ﬁrst cousin
with UC, and a CD-affected sibling pair was found to
have a second cousin with UC). All study subjects were
whites of European descent. Ashkenazi Jewish ethnicity
was reported in eight of the 62 families.
Genotyping
We genotyped our study subjects at 395 microsatellite
loci in the ABI PRISM Linkage Mapping Set Version 2
(PE Applied Biosystems). Five microsatellite loci in the
ABI PRISM Linkage Mapping Set Version 2 were found
to be problematic and were not included in the genome
scan. Up to twelve ﬂuorescent dye-labeled microsatellite
polymerase chain reaction amplimers from single DNA
samples were pooled together, heat denatured, and
loaded into ABI 377 DNA Sequencers (PE Applied Bios-
ystems) for GENESCAN data collection. The data were
analyzed and alleles assigned using the TrueAllele soft-
ware (Cybergenetics).
An additional 356 microsatellite loci in theWeber ver-
sion 9 screening set were genotyped by theNHLBIMam-
malian Genotyping Service at the Center for Medical
Genetics in Marshﬁeld, Wisconsin. The genetic spacing
between the total of 751 microsatellite loci averaged 4.6
centimorgans (cM), according to comprehensive genetic
maps of microsatellite loci by Broman et al. (1998).
Statistical Analyses
Mendelian inheritance was checked using the Ped-
Check program, which uses the individual’s genotype
information to check for parent-child inconsistencies
and too many alleles in a sibship and then uses genotype
elimination to ﬁnd more subtle errors (O’Connell and
Weeks 1998). Allele frequencies for each microsatellite
locus were estimated by counting alleles in unrelated
individuals, augmented by the addition of nontransmit-
ted alleles derived from each nuclear family unit.
Single- and multipoint nonparametric linkage analyses
were carried out by means of the “Spairs” scoring function
in the GENEHUNTER-PLUS modiﬁcation of the
GENEHUNTER package (Kruglyak et al. 1996; Kong
and Cox 1997). GENEHUNTER-PLUS performs a like-
lihood-based, nonparametric analysis of allele and hap-
lotype sharing in affected-relative pairs and computes a
nonparametric LOD score (Kong and Cox 1997). The
X-linked version of GENEHUNTER-PLUS was used for
the chromosome X analyses. To reduce the potential for
misspeciﬁcation of marker order in the multipoint anal-
yses, only those Weber version 9 markers that were 2
cM away from the nearest ABI marker were included in
the multipoint analyses, giving a total of 588 microsat-
ellite loci with an average genetic spacing of 5.9 cM in
the multipoint analyses. We observed the guidelines for
interpreting and reporting linkage results proposed by
Lander and Kruglyak (Lander and Kruglyak 1995).
Results
Loci with single-point GENEHUNTER-PLUS P values
! .05 are shown in table 1. The two microsatellite loci
with the greatest single-point LOD scores are the ad-
jacent D14S261 and D14S283 loci on chromosome
14q11-12 (LOD = 3.00 and 1.70, respectively).Nominal
evidence for linkage is observed at two adjacent markers
on chromosome 18q22 (D18S61 and ATA82B02).
A summary of the information content for each chro-
mosome from the GENEHUNTER multipoint output
is shown in table 2. The average information content
across the genome is 0.74. This reﬂects the relatively
high genotyping information from connecting relatives
and the high density of genotyped genetic markers in
our study. The GENEHUNTER-PLUS multipoint LOD
score curves for chromosomes with nominal multipoint
P values ! .05 are shown in ﬁgure 1. The maximal
multipoint LOD score in our genome scan is at
D14S261 on chromosome 14q11 (LOD = 3.60). The
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Table 1




(cM) Microsatellite LOD P
1 29.9 D1S1597 1.48 .0092
2 194.5 D2S117 1.30 .014
9 44.3 D9S1121 1.40 .011
9 147.9 D9S164 1.01 .031
12 0.0 D12S352 .91 .041
14 6.5 D14S261 3.00 .0002
14 13.9 D14S283 1.70 .0051
17 22.2 D17S974 .91 .041
18 105.0 D18S61 1.34 .013
18 106.8 ATA82B02 1.07 .026
19 9.8 D19S591 1.60 .0067
20 47.5 D20S477 1.16 .021
Table 2






1 282 .74 .89 .55
2 257 .76 .87 .61
3 217 .75 .89 .56
4 203 .70 .90 .49
5 194 .76 .91 .50
6 181 .72 .85 .59
7 175 .74 .88 .59
8 164 .76 .91 .63
9 155 .76 .87 .58
10 169 .75 .91 .62
11 145 .75 .88 .58
12 165 .76 .91 .59
13 105 .70 .86 .58
14 128 .71 .84 .62
15 117 .76 .88 .61
16 121 .76 .86 .64
17 126 .73 .86 .59
18 127 .75 .88 .57
19 91 .74 .86 .61
20 96 .75 .88 .61
21 55 .73 .85 .53
22 48 .76 .89 .58
X 88 .77 .92 .56
a Information content as calculated by GENE-
HUNTER-PLUS.
b Number of locations considered on chromosome
(one location every 1 cM).
evidence for linkage at D14S261 is at the threshold for
declaring signiﬁcant linkage in a genome scan (Lander
and Kruglyak 1995). The 1-LOD-unit support interval
extends to 4 cM q-telomeric from D14S261, and P val-
ues ! .05 are observed over a 13-cM region q-telomeric
from D14S261. There are no other regions for which
the Lander and Kruglyak criteria for declaring signiﬁ-
cant or suggestive linkage in a genome scan are satisﬁed
(Lander and Kruglyak 1995). Nominal evidence for
linkage with multipoint P values ! .05 is present near
D2S117 (LOD = 1.25), near D3S3045 (LOD = 1.31),
between D7S40 and D7S648 (LOD = 0.91), and near
D18S61 (LOD = 1.15).
Discussion
Our genome scan using 751 microsatellite loci in 127
CD-affected relative pairs has found strong evidence for
linkage between CD and chromosome 14q11-12. The
maximal linkage evidence in this region (multipoint
LOD = 3.60 at D14S261) is at the threshold for declaring
signiﬁcant linkage in a genome scan (Lander and Krug-
lyak 1995). Recently, investigators from Cedars-Sinai/
Parke Davis reported the results of a genome scan in 65
CD-affected sibling pairs (Ma et al. 1999). They found
evidence suggestive of linkage (multipoint LOD = 2.8)
to D14S261 (Ma et al. 1999). In addition, Cho et al.
found nominal evidence for linkage to this general region
of chromosome 14 in their subset of mixed families con-
taining both CD- and UC-affected individuals (multi-
point LOD = 1.53, , at D14S608) (Cho et al.P = .004
1998). Our ﬁnding of signiﬁcant linkage together with
the Cedars-Sinai/Parke Davis ﬁnding of suggestive link-
age to D14S261 satisﬁes stringent criteria for declaring
conﬁrmed linkage to this region of chromosome 14
(Lander and Kruglyak 1995). We propose that the CD-
linked locus on chromosome 14q11-12 should be des-
ignated the IBD4 locus. The fact that linkage to this
locus has not been detected in three of the ﬁve previously
published genome scans in IBD is consistent with the
expectation that enormous sample sizes are needed for
any one study to detect all of the loci that contribute to
the genetic susceptibility of a complex trait. In the recent
Genetic Analysis Workshop 11, analysis of a simulated
data set of a complex trait with four genetic loci, genetic
heterogeneity, epistasis, multiple disease alleles at a single
locus, and an interacting environmental factor at one of
the genetic loci, showed that all of the loci were detected
only when all 2,500 nuclear families in the simulated
data set were analyzed as one sample (Mandal et al.
1999).
Candidate genes on chromosome 14q11-12 include
the T-cell receptor alpha and delta genes (Croce et al.
1985; Chien et al. 1987); interferon-stimulated tran-
scription factor 3, gamma gene (McCusker et al. 1999);
a cluster of genes for proteasomes responsible for major
histocompatibility complex class I-restricted antigen
presentation, including the proteasome subunit, beta-
type, 5, proteasome activator subunit 1, and proteasome
activator subunit 2 genes (McCusker et al. 1997;
Kloetzel et al. 1999); a cluster of hematopoietic serine
protease genes, including the cytotoxic T-lymphocyte-
associated serine esterase 1, granzyme H, and cathepsin
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Figure 1 The results of multipoint nonparametric linkage analyses using the Spairs scoring function in theGENEHUNTER-PLUSmodiﬁcation
of the GENEHUNTER package (Kruglyak et al. 1996; Kong and Cox 1997) are plotted as the GENEHUNTER-PLUS LOD scores on the Y
axis (scale up to LOD = 4) against the genetic distance in centimorgans from the ﬁrst microsatellite locus on the X axis for chromosomes with
multipoint nominal P values ! .05.
G genes (Hanson et al. 1990); the leukotriene B4 re-
ceptor gene (Somers et al. 1997); and the antiapoptotic
defender against cell death and BCL2-like 2 genes (Yu-
lug et al. 1995; Gibson et al. 1996).
We did not ﬁnd evidence for linkage between CD and
the IBD1, IBD2, or IBD3 loci (Hugot et al. 1996; Oh-
men et al. 1996; Parkes et al. 1996; Satsangi et al. 1996;
Akolkar et al. 1998; Brant et al. 1998; Cavanaugh et
al. 1998; Cho et al. 1998; Curran et al. 1998; Duerr et
al. 1998; Annese et al. 1999; Hampe et al. 1999a,
1999b; Ma et al. 1999; Silverberg et al. 1999; Yang et
al. 1999). Since the multipoint information content in
these regions is relatively high in our study (0.79 at
D16S753 within the IBD1 locus, 0.83 at D12S83within
the IBD2 locus, and 0.84 at D6S2439 within the IBD3
locus), our lack of replication of linkage is not attrib-
utable to low informativeness of the markers that we
genotyped in these regions. We assume that we are un-
able to replicate linkage to IBD1 and IBD3 because of
locus heterogeneity within CD and lack of sufﬁcient
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sample size to replicate the linkage. For a complex trait
such as CD, it is expected that a substantially larger
data set would be required to replicate a linkage than
was required to detect it in the ﬁrst place (Suarez et al.
1994). Although we and others have previously repli-
cated linkage between IBD and the IBD2 locus (Satsangi
et al. 1996; Akolkar et al. 1998; Curran et al. 1998;
Duerr et al. 1998; Hampe et al. 1999a; Ma et al. 1999),
subsequent data suggests that most of the evidence for
linkage to IBD2 comes from UC families with signiﬁ-
cantly less linkage evidence in CD families and probable
locus heterogeneity within CD at the IBD2 locus (M.
Parkes, M. M. Barmada, J. Satsangi, D. E. Weeks, D.
P. Jewell, and R. H. Duerr, unpublished data).
Our ﬁnding of nominal evidence for linkage to two
adjacent loci on chromosome 18q22 (D18S61 and
ATA82B02) is noteworthy, in view of the fact that Ma
et al. (1999) also found nominal evidence for linkage
between CD and a region centered on D18S474 on
chromosome 18q21 (LOD = 1.1 in all families with CD
and LOD = 1.9 in Jewish families with CD in the Ma
et al. study). While D18S474 is located 33.7 cM cen-
tromeric from D18S61 on the Broman et al. genetic map
(Broman et al. 1998), we and Ma et al. may have de-
tected the same locus on chromosome 18q, given the
limited resolution of allele/haplotype sharing methods
of nonparametric linkage analysis for ﬁne localization
of disease-susceptibility loci (Boehnke 1994; Kruglyak
and Lander 1995, 1996; Roberts et al. 1999).
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